CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 124 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,306 | -45.6% | 19,364 | -52.3% | 0.00% | – |
| Q1 2023 | $61,277 | -7.8% | 40,581 | -2.4% | 0.00% | – |
| Q4 2022 | $66,494 | +23.1% | 41,559 | +107.2% | 0.00% | – |
| Q1 2022 | $54,000 | -33.3% | 20,061 | +6.6% | 0.00% | – |
| Q4 2021 | $81,000 | -84.9% | 18,820 | -77.8% | 0.00% | – |
| Q2 2021 | $536,000 | +300.0% | 84,724 | +387.1% | 0.00% | – |
| Q1 2021 | $134,000 | +32.7% | 17,394 | +13.3% | 0.00% | – |
| Q4 2020 | $101,000 | -20.5% | 15,349 | -19.9% | 0.00% | – |
| Q3 2020 | $127,000 | -5.2% | 19,160 | +19.5% | 0.00% | – |
| Q2 2020 | $134,000 | – | 16,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |